February 12, 2008; 70 (7) Articles
Anti-NMDA receptor encephalitis in Japan
Long-term outcome without tumor removal
T. Iizuka, F. Sakai, T. Ide, T. Monzen, S. Yoshii, M. Iigaya, K. Suzuki, D. R. Lynch, N. Suzuki, T. Hata, J. Dalmau
First published September 26, 2007, DOI: https://doi.org/10.1212/01.wnl.0000278388.90370.c3
T. Iizuka
F. Sakai
T. Ide
T. Monzen
S. Yoshii
M. Iigaya
K. Suzuki
D. R. Lynch
N. Suzuki
T. Hata
Anti-NMDA receptor encephalitis in Japan
Long-term outcome without tumor removal
T. Iizuka, F. Sakai, T. Ide, T. Monzen, S. Yoshii, M. Iigaya, K. Suzuki, D. R. Lynch, N. Suzuki, T. Hata, J. Dalmau
Neurology Feb 2008, 70 (7) 504-511; DOI: 10.1212/01.wnl.0000278388.90370.c3
Citation Manager Formats
Make Comment
See Comments

Article Information
vol. 70 no. 7 504-511
PubMed:
Print ISSN:
Online ISSN:
History:
- First Published September 26, 2007.
Article Versions
- Previous version (September 26, 2007 - 12:55).
- You are viewing the most recent version of this article.
Copyright & Usage:
© 2008
Author Disclosures
- T. Iizuka, MD,
- F. Sakai, MD,
- T. Ide, MD,
- T. Monzen, MD,
- S. Yoshii, MD,
- M. Iigaya, MD,
- K. Suzuki, MD,
- D. R. Lynch, MD, PhD,
- N. Suzuki, MD,
- T. Hata, MD and
- J. Dalmau, MD, PhD
- T. Iizuka, MD,
- F. Sakai, MD,
- T. Ide, MD,
- T. Monzen, MD,
- S. Yoshii, MD,
- M. Iigaya, MD,
- K. Suzuki, MD,
- D. R. Lynch, MD, PhD,
- N. Suzuki, MD,
- T. Hata, MD and
- J. Dalmau, MD, PhD
- From the Department of Neurology, School of Medicine, Kitasato University, Kanagawa, Japan (T. Iizuka, F.S., T. Ide, T.M., S.Y., M.I., K.S.); Department of Neurology, Divisions of Neuro-oncology and Pediatric Neurology, University of Pennsylvania, Philadelphia, PA (D.R.L., J.D.); Department of Neurology, School of Medicine, Keio University, Tokyo, Japan (N.S.); and Department of Neurology, Shizuoka Municipal Shimizu Hospital, Shizuoka, Japan (T.H.).
- Address correspondence and reprint requests to Dr. Takahiro Iizuka, Department of Neurology, School of Medicine, Kitasato University, 1-15-1 Kitasato, Sagamihara, Kanagawa, 228-8555, Japantakahiro{at}med.kitasato-u.ac.jp
Article usage
Cited By...
Letters: Rapid online correspondence
No comments have been published for this article.
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
More Online
Dr. Sevil Yaşar and Dr. Behnam Sabayan
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Special Article
NMDA receptor encephalitis and other antibody-mediated disorders of the synapseThe 2016 Cotzias LectureJosep Dalmau et al.Neurology, December 05, 2016 -
Article
Decreased occipital lobe metabolism by FDG-PET/CTAn anti–NMDA receptor encephalitis biomarkerJohn C. Probasco, Lilja Solnes, Abhinav Nalluri et al.Neurology: Neuroimmunology & Neuroinflammation, November 15, 2017 -
Article
Bortezomib for treatment of therapy-refractory anti-NMDA receptor encephalitisFranziska Scheibe, Harald Prüss, Annerose M. Mengel et al.Neurology, December 21, 2016 -
Article
Clinical significance of anti-NMDAR concurrent with glial or neuronal surface antibodiesEugenia Martinez-Hernandez, Mar Guasp, Anna García-Serra et al.Neurology, March 11, 2020